Anoctamin 1 controls bone resorption by coupling Cl- channel activation with RANKL-RANK signaling transduction

Nat Commun. 2022 May 24;13(1):2899. doi: 10.1038/s41467-022-30625-9.

Abstract

Osteoclast over-activation leads to bone loss and chloride homeostasis is fundamental importance for osteoclast function. The calcium-activated chloride channel Anoctamin 1 (also known as TMEM16A) is an important chloride channel involved in many physiological processes. However, its role in osteoclast remains unresolved. Here, we identified the existence of Anoctamin 1 in osteoclast and show that its expression positively correlates with osteoclast activity. Osteoclast-specific Anoctamin 1 knockout mice exhibit increased bone mass and decreased bone resorption. Mechanistically, Anoctamin 1 deletion increases intracellular Cl- concentration, decreases H+ secretion and reduces bone resorption. Notably, Anoctamin 1 physically interacts with RANK and this interaction is dependent upon Anoctamin 1 channel activity, jointly promoting RANKL-induced downstream signaling pathways. Anoctamin 1 protein levels are substantially increased in osteoporosis patients and this closely correlates with osteoclast activity. Finally, Anoctamin 1 deletion significantly alleviates ovariectomy induced osteoporosis. These results collectively establish Anoctamin 1 as an essential regulator in osteoclast function and suggest a potential therapeutic target for osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anoctamin-1 / metabolism*
  • Bone Resorption* / metabolism
  • Female
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • NFATC Transcription Factors / metabolism
  • Osteoclasts / metabolism
  • Osteogenesis / genetics
  • Osteoporosis* / metabolism
  • Ovariectomy
  • RANK Ligand / genetics
  • RANK Ligand / metabolism

Substances

  • ANO1 protein, mouse
  • Anoctamin-1
  • NFATC Transcription Factors
  • RANK Ligand